newsfilter
← Latest News
ACCESS Newswire·

NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete

SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, is pleased